You can buy or sell Ocugen, Inc and other stocks, options, and ETFs commission-free!
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. The listed name for OCGN is Ocugen, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 26, Pre-Market